With commercial insurance: SAPHNELO Co-pay Savings Program — as little as $0, up to $16,500 per calendar year. With Medicare: the Saphnelo card can’t be used. All 2 foundation funds we checked are closed as of September 28, 2026.
Which form this covers: The IV infusion is clinic-billed. The new Saphnelo Pen (weekly SC self-injection) is a pharmacy-benefit product. The program lists both.
Program covers the cost of the drug, infusion administration, injection training, and does not cover the costs for office visits or any other associated costs.
Checked September 28, 2026 · Source ↗
AZ&Me is designed to help qualifying people without insurance and those on Medicare who are having trouble affording their AstraZeneca medications.
Checked September 28, 2026 · Source 1 ↗ · Source 2 ↗
Saphnelo’s card can’t be used with Medicare. These funds may help. They open and close with donations, so call before telling a Saphnelo patient no.
Checked September 28, 2026 · Source ↗
Saphnelo is billed under J0491. The Saphnelo copay card can’t be used when Medicare or another government plan pays for Saphnelo (HHS OIG guidance).
Last checked September 28, 2026 against each program’s own pages (links above). Methodology →
Program details are for information only and are not a guarantee of eligibility or benefit. Confirm current terms with the program before you rely on them.